Company Filing History:
1 out of 28 
1 out of 14 Years Active: 2011-2013
Title: Clément Rioux: Innovator in Vaccine Development
Introduction
Clément Rioux is a notable inventor based in Ville-de-Cap-Rouge, Canada. He has made significant contributions to the field of vaccine development, particularly in relation to Group B streptococcus infections. With a total of 2 patents to his name, Rioux's work has implications for both animal health and medical research.
Latest Patents
Rioux's latest patents focus on Group B (GBS) proteins and the polynucleotides encoding them. These proteins are antigenic and serve as useful vaccine components for the prophylaxis or therapy of infections in animals. Additionally, his patents disclose recombinant methods for producing these protein antigens, as well as diagnostic assays for detecting bacterial infections. The significance of his work lies in its potential to improve vaccine efficacy and diagnostic capabilities in veterinary medicine.
Career Highlights
Throughout his career, Clément Rioux has worked with Id Biomedical Corporation and Id Biomedical Corporation of Quebec. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of immunology and vaccine research.
Collaborations
Some of his notable coworkers include Bernard R. Brodeur and Martine Boyer. Their collaborative efforts have contributed to advancements in the understanding and treatment of bacterial infections.
Conclusion
Clément Rioux's contributions to vaccine development and his innovative patents highlight his role as a key figure in the field of immunology. His work continues to influence the development of effective vaccines and diagnostic tools for animal health.